M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer

BACKGROUND: Prostate cancer (PCa) is poor response to the immunotherapy for its high heterogeneity of immune microenvironment. In this study, we aim to introduce a new immune subtype for PCa involving M2 tumour associated macrophages (M2-TAMs). METHODS: Three hundred and sixty-two PCa patients and m...

Descripción completa

Detalles Bibliográficos
Autores principales: JiaWei, Zhou, ChunXia, Dou, CunDong, Liu, Yang, Liu, JianKun, Yang, HaiFeng, Duan, Cheng, Yang, ZhiPeng, Huang, HongYi, Wang, DeYing, Liao, ZhiJian, Liang, Xiao, Xie, QiZhao, Zhou, KangYi, Xue, WenBing, Guo, Ming, Xia, JunHao, Zhou, JiMing, Bao, ShanChao, Zhao, MingKun, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158194/
https://www.ncbi.nlm.nih.gov/pubmed/34032524
http://dx.doi.org/10.1080/07853890.2021.1924396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158194/
https://www.ncbi.nlm.nih.gov/pubmed/34032524
http://dx.doi.org/10.1080/07853890.2021.1924396

Ejemplares similares